Clinical course of COVID-19 infection in a melanoma patient treated with nivolumab and bempegaldesleukin: a case report니볼루맙과 베페갈데스류킨으로 치료받은 흑색종 환자의 코로나19 감염 임상 경과: 증례 보고Case Reports Published on 2022-09-012022-09-12 Journal: Immunotherapy [Category] 진단, [키워드] administration available data bempegaldesleukin cancer patient Case report clinical Clinical characteristics Combination Course COVID-19 COVID-19 infection Cytokines IL-2 Immune checkpoint inhibitor immune-related pneumonitis Immunotherapy Laboratory mechanism of action Melanoma nivolumab nivolumab. outcome Patient Pneumonia treated Treatment [DOI] 10.2217/imt-2021-0331 PMC 바로가기 [Article Type] Case Reports
[Immune-related pneumonitis: A differential diagnosis of SARS-CoV-2 pneumonia]Article Published on 2022-09-012023-07-10 Journal: Revue des maladies respiratoires [Category] COVID19(2023년), [키워드] Cancer pulmonaire COVID-19 Immune-related adverse events (IrAE) immune-related pneumonitis Immunothérapie Immunotherapy irAE Lung neoplasm Pneumopathie immuno-induite SARS-CoV-2 [DOI] 10.1016/j.rmr.2022.07.001 PMC 바로가기